These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11745198)

  • 1. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.
    Masuya D; Huang C; Liu D; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Haba R; Yokomise H
    Cancer; 2001 Nov; 92(10):2628-38. PubMed ID: 11745198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
    Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
    J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
    Kojima H; Shijubo N; Abe S
    Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.
    Yuan A; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT; Yang PC
    Int J Cancer; 2000 Nov; 89(6):475-83. PubMed ID: 11102890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
    Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
    Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.
    Nakashima T; Huang CL; Liu D; Kameyama K; Masuya D; Ueno M; Haba R; Yokomise H
    Med Sci Monit; 2004 Jun; 10(6):BR157-65. PubMed ID: 15173661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
    Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
    Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
    Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer.
    Yuan A; Yu CJ; Kuo SH; Chen WJ; Lin FY; Luh KT; Yang PC; Lee YC
    J Clin Oncol; 2001 Jan; 19(2):432-41. PubMed ID: 11208836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
    Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
    Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression.
    Ushijima C; Tsukamoto S; Yamazaki K; Yoshino I; Sugio K; Sugimachi K
    Lung Cancer; 2001 Nov; 34(2):233-41. PubMed ID: 11679182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
    Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
    Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
    Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
    Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
    Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.